ORANGE BELGIUM (OBEL.BR) Stock Fundamental Analysis

EBR:OBEL • BE0003735496

19.5 EUR
0 (0%)
Last: Feb 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to OBEL. OBEL was compared to 6 industry peers in the Wireless Telecommunication Services industry. There are concerns on the financial health of OBEL while its profitability can be described as average. OBEL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year OBEL was profitable.
  • OBEL had a positive operating cash flow in the past year.
  • Each year in the past 5 years OBEL has been profitable.
  • OBEL had a positive operating cash flow in each of the past 5 years.
OBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFOBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • With a Return On Assets value of 0.93%, OBEL perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 3.88%, OBEL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Return On Invested Capital of OBEL (3.63%) is better than 66.67% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for OBEL is below the industry average of 6.47%.
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROIC 3.64%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
OBEL.BR Yearly ROA, ROE, ROICOBEL.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • OBEL's Profit Margin of 1.89% is on the low side compared to the rest of the industry. OBEL is outperformed by 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of OBEL has declined.
  • OBEL's Operating Margin of 7.62% is in line compared to the rest of the industry. OBEL outperforms 50.00% of its industry peers.
  • OBEL's Operating Margin has improved in the last couple of years.
  • OBEL has a better Gross Margin (68.11%) than 100.00% of its industry peers.
  • OBEL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
OBEL.BR Yearly Profit, Operating, Gross MarginsOBEL.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OBEL is destroying value.
  • The number of shares outstanding for OBEL has been increased compared to 1 year ago.
  • Compared to 5 years ago, OBEL has more shares outstanding
  • OBEL has a better debt/assets ratio than last year.
OBEL.BR Yearly Shares OutstandingOBEL.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OBEL.BR Yearly Total Debt VS Total AssetsOBEL.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • OBEL has an Altman-Z score of 0.96. This is a bad value and indicates that OBEL is not financially healthy and even has some risk of bankruptcy.
  • OBEL has a worse Altman-Z score (0.96) than 66.67% of its industry peers.
  • The Debt to FCF ratio of OBEL is 23.91, which is on the high side as it means it would take OBEL, 23.91 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of OBEL (23.91) is worse than 83.33% of its industry peers.
  • OBEL has a Debt/Equity ratio of 1.92. This is a high value indicating a heavy dependency on external financing.
  • OBEL's Debt to Equity ratio of 1.92 is on the low side compared to the rest of the industry. OBEL is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Altman-Z 0.96
ROIC/WACC0.69
WACC5.28%
OBEL.BR Yearly LT Debt VS Equity VS FCFOBEL.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • OBEL has a Current Ratio of 0.49. This is a bad value and indicates that OBEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • OBEL has a worse Current ratio (0.49) than 83.33% of its industry peers.
  • OBEL has a Quick Ratio of 0.49. This is a bad value and indicates that OBEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • OBEL has a worse Quick ratio (0.46) than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.46
OBEL.BR Yearly Current Assets VS Current LiabilitesOBEL.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • OBEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 780.62%, which is quite impressive.
  • OBEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.64% yearly.
  • The Revenue has decreased by -0.39% in the past year.
  • The Revenue has been growing by 8.26% on average over the past years. This is quite good.
EPS 1Y (TTM)780.62%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%119.69%
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%-1.52%

3.2 Future

  • The Earnings Per Share is expected to decrease by -10.15% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 0.94% on average over the next years.
EPS Next Y-6.88%
EPS Next 2Y-36.27%
EPS Next 3Y-36.38%
EPS Next 5Y-10.15%
Revenue Next Year4.91%
Revenue Next 2Y2.42%
Revenue Next 3Y3.44%
Revenue Next 5Y0.94%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OBEL.BR Yearly Revenue VS EstimatesOBEL.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
OBEL.BR Yearly EPS VS EstimatesOBEL.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • OBEL is valuated quite expensively with a Price/Earnings ratio of 32.50.
  • Compared to the rest of the industry, the Price/Earnings ratio of OBEL indicates a slightly more expensive valuation: OBEL is more expensive than 66.67% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.19. OBEL is around the same levels.
  • With a Price/Forward Earnings ratio of 93.26, OBEL can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, OBEL is valued a bit more expensive than 66.67% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, OBEL is valued quite expensively.
Industry RankSector Rank
PE 32.5
Fwd PE 93.26
OBEL.BR Price Earnings VS Forward Price EarningsOBEL.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, OBEL is valued cheaper than 83.33% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, OBEL is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.95
EV/EBITDA 5.42
OBEL.BR Per share dataOBEL.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The decent profitability rating of OBEL may justify a higher PE ratio.
  • OBEL's earnings are expected to decrease with -36.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.27%
EPS Next 3Y-36.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OBEL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORANGE BELGIUM

EBR:OBEL (2/16/2026, 7:00:00 PM)

19.5

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)02-06
Earnings (Next)07-22
Inst Owners5.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.31B
Revenue(TTM)1.98B
Net Income(TTM)37.35M
Analysts46.67
Price Target17.34 (-11.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15.7%
PT rev (3m)-15.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)184.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 32.5
Fwd PE 93.26
P/S 0.66
P/FCF 14.95
P/OCF 2.78
P/B 1.37
P/tB N/A
EV/EBITDA 5.42
EPS(TTM)0.6
EY3.08%
EPS(NY)0.21
Fwd EY1.07%
FCF(TTM)1.3
FCFY6.69%
OCF(TTM)7.01
OCFY35.97%
SpS29.36
BVpS14.28
TBVpS-9.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.88
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROCE 4.85%
ROIC 3.64%
ROICexc 3.7%
ROICexgc 7.68%
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
FCFM 4.44%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
ROICexc(3y)4.56%
ROICexc(5y)5.09%
ROICexgc(3y)11.41%
ROICexgc(5y)10.53%
ROCE(3y)6.22%
ROCE(5y)6.69%
ROICexgc growth 3Y-7.87%
ROICexgc growth 5Y2.19%
ROICexc growth 3Y-16.49%
ROICexc growth 5Y-3.51%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Debt/EBITDA 2.97
Cap/Depr 81.82%
Cap/Sales 19.45%
Interest Coverage 1.49
Cash Conversion 76.13%
Profit Quality 235.44%
Current Ratio 0.49
Quick Ratio 0.46
Altman-Z 0.96
F-Score7
WACC5.28%
ROIC/WACC0.69
Cap/Depr(3y)156.85%
Cap/Depr(5y)119.41%
Cap/Sales(3y)34.82%
Cap/Sales(5y)26.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)780.62%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%119.69%
EPS Next Y-6.88%
EPS Next 2Y-36.27%
EPS Next 3Y-36.38%
EPS Next 5Y-10.15%
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%-1.52%
Revenue Next Year4.91%
Revenue Next 2Y2.42%
Revenue Next 3Y3.44%
Revenue Next 5Y0.94%
EBIT growth 1Y12.37%
EBIT growth 3Y22.15%
EBIT growth 5Y18.64%
EBIT Next Year291.76%
EBIT Next 3Y55.8%
EBIT Next 5Y29.53%
FCF growth 1Y116.96%
FCF growth 3Y-9.07%
FCF growth 5Y-7.65%
OCF growth 1Y24.22%
OCF growth 3Y10.98%
OCF growth 5Y8.17%

ORANGE BELGIUM / OBEL.BR FAQ

Can you provide the ChartMill fundamental rating for ORANGE BELGIUM?

ChartMill assigns a fundamental rating of 3 / 10 to OBEL.BR.


Can you provide the valuation status for ORANGE BELGIUM?

ChartMill assigns a valuation rating of 3 / 10 to ORANGE BELGIUM (OBEL.BR). This can be considered as Overvalued.


How profitable is ORANGE BELGIUM (OBEL.BR) stock?

ORANGE BELGIUM (OBEL.BR) has a profitability rating of 6 / 10.


How financially healthy is ORANGE BELGIUM?

The financial health rating of ORANGE BELGIUM (OBEL.BR) is 0 / 10.


What is the earnings growth outlook for ORANGE BELGIUM?

The Earnings per Share (EPS) of ORANGE BELGIUM (OBEL.BR) is expected to decline by -6.88% in the next year.